セッション情報 Poster Presentation(HBP)

タイトル

IF-P2-3 Hepatitis C Virus NS4B Protein Targets STING and Abrogates RIG-I-mediated Type-I Interferon-dependent Innate Immunity

演者
共同演者
抄録 Summaiy : Hepatitis C virus (HCV) infection blocks cellular interferon (IFN)一mediated antiviral signalmgthrough cleavage of Cardif by HCV-NS3/4A serine protease. Like NS3/4ANS4B protei’n strongly blocksretinoic-acid-inducible protein I(RIG-1)一mediated IFN一βproduction signaling(Tasaka et al. J Gen Viro12007) ; howeverthe underlying molecular mechanisms are not well understood. Recentlythe stimulatorof interferon genes(ST工NG)was identified as an activator of RIG-I signaling. ST工NG possesses a structuralhomology domain with flaviviral NS4Bwhich suggest a direct protein-protein interactionln the presentstudywe investigated the molecular mechanisms by which NS 4 B targets RIG-1 induced and STINGmediated IFN-B production signaling. IFN-P promoter reporter assay showed that IFN-P promoter activa-tion induced by RIG-1 or Cardif was significantly suppressed by both NS4B and NS3/4Awhile STING-induced IFN-S activation was suppressed by NS4B but not by NS3/4Asuggesting that NS4B had a dis-tinct point of interaction. lmmunostaining showed that STING colocalized with NS4B in the endoplasmicreticulum. lmmunoprecipitation and bimolecular fluorescence complementation (BiFC) assays demon-strated that NS4B specifically bound STING. lntriguinglyNS4B expression blocked the protein interac-tion between STING and Cardifwhich is required for robust IFN-P activation. NS4B truncation assaysshowed that its N-terminuscontaining the STING-homology domainwas necessary for the suppression ofIFN-P promoter activation. NS4B suppressed residual IFN-P activation by an NS3/4A£leaved Cardif (Car-dif1-508)suggesting that NS3/4A and NS4B may cooperate in the blockade of IFN一βproduction.Conclusion : NS4B suppr/esses RIG-1-mediated IFN-P production signaling through a direct protein inter-action with STING. Disruption of that interaction may restore cellular antiviral responses and may consti-tute a novel therapeutic strategy against HCV.
索引用語